IL-38-SPECIFIC ANTIBODIES

This invention relates to antibodies specific for human interleukin-38 (IL-38), including isolated antibodies, or antigen-binding fragments thereof. The antibodies, or antigen-binding fragments thereof, described here partially or fully block, inhibit, or neutralize a biological activity of IL 38. M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HARMAN, BEN, NIKITIN, PAVEL A, ROBINSON, MATTHEW K, LUNDGREN, KAREN, DOWLING, JOHN P
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HARMAN, BEN
NIKITIN, PAVEL A
ROBINSON, MATTHEW K
LUNDGREN, KAREN
DOWLING, JOHN P
description This invention relates to antibodies specific for human interleukin-38 (IL-38), including isolated antibodies, or antigen-binding fragments thereof. The antibodies, or antigen-binding fragments thereof, described here partially or fully block, inhibit, or neutralize a biological activity of IL 38. Methods described here relate to inhibiting tumor growth or metastasis in an individual afflicted by tumor growth and/or metastasis. La présente invention concerne des anticorps spécifiques de l'interleukine 38 humaine (IL-38) comprenant des anticorps isolés ou leurs fragments de liaison à l'antigène. Les anticorps ou leurs fragments de liaison à l'antigène susmentionnés bloquent, inhibent ou neutralisent, partiellement ou totalement, une activité biologique de l'IL-38. Les procédés susmentionnés concernent l'inhibition de la croissance tumorale ou de la métastase chez un individu présentant une croissance tumorale et/ou une métastase.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3149198A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3149198A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3149198A13</originalsourceid><addsrcrecordid>eNrjZJD09NE1ttANDnB19nTzdFZw9AvxdPJ38XQN5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8c6OxoYmloaWFo6GxkQoAQCwXB8u</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IL-38-SPECIFIC ANTIBODIES</title><source>esp@cenet</source><creator>HARMAN, BEN ; NIKITIN, PAVEL A ; ROBINSON, MATTHEW K ; LUNDGREN, KAREN ; DOWLING, JOHN P</creator><creatorcontrib>HARMAN, BEN ; NIKITIN, PAVEL A ; ROBINSON, MATTHEW K ; LUNDGREN, KAREN ; DOWLING, JOHN P</creatorcontrib><description>This invention relates to antibodies specific for human interleukin-38 (IL-38), including isolated antibodies, or antigen-binding fragments thereof. The antibodies, or antigen-binding fragments thereof, described here partially or fully block, inhibit, or neutralize a biological activity of IL 38. Methods described here relate to inhibiting tumor growth or metastasis in an individual afflicted by tumor growth and/or metastasis. La présente invention concerne des anticorps spécifiques de l'interleukine 38 humaine (IL-38) comprenant des anticorps isolés ou leurs fragments de liaison à l'antigène. Les anticorps ou leurs fragments de liaison à l'antigène susmentionnés bloquent, inhibent ou neutralisent, partiellement ou totalement, une activité biologique de l'IL-38. Les procédés susmentionnés concernent l'inhibition de la croissance tumorale ou de la métastase chez un individu présentant une croissance tumorale et/ou une métastase.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210204&amp;DB=EPODOC&amp;CC=CA&amp;NR=3149198A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210204&amp;DB=EPODOC&amp;CC=CA&amp;NR=3149198A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HARMAN, BEN</creatorcontrib><creatorcontrib>NIKITIN, PAVEL A</creatorcontrib><creatorcontrib>ROBINSON, MATTHEW K</creatorcontrib><creatorcontrib>LUNDGREN, KAREN</creatorcontrib><creatorcontrib>DOWLING, JOHN P</creatorcontrib><title>IL-38-SPECIFIC ANTIBODIES</title><description>This invention relates to antibodies specific for human interleukin-38 (IL-38), including isolated antibodies, or antigen-binding fragments thereof. The antibodies, or antigen-binding fragments thereof, described here partially or fully block, inhibit, or neutralize a biological activity of IL 38. Methods described here relate to inhibiting tumor growth or metastasis in an individual afflicted by tumor growth and/or metastasis. La présente invention concerne des anticorps spécifiques de l'interleukine 38 humaine (IL-38) comprenant des anticorps isolés ou leurs fragments de liaison à l'antigène. Les anticorps ou leurs fragments de liaison à l'antigène susmentionnés bloquent, inhibent ou neutralisent, partiellement ou totalement, une activité biologique de l'IL-38. Les procédés susmentionnés concernent l'inhibition de la croissance tumorale ou de la métastase chez un individu présentant une croissance tumorale et/ou une métastase.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD09NE1ttANDnB19nTzdFZw9AvxdPJ38XQN5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8c6OxoYmloaWFo6GxkQoAQCwXB8u</recordid><startdate>20210204</startdate><enddate>20210204</enddate><creator>HARMAN, BEN</creator><creator>NIKITIN, PAVEL A</creator><creator>ROBINSON, MATTHEW K</creator><creator>LUNDGREN, KAREN</creator><creator>DOWLING, JOHN P</creator><scope>EVB</scope></search><sort><creationdate>20210204</creationdate><title>IL-38-SPECIFIC ANTIBODIES</title><author>HARMAN, BEN ; NIKITIN, PAVEL A ; ROBINSON, MATTHEW K ; LUNDGREN, KAREN ; DOWLING, JOHN P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3149198A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HARMAN, BEN</creatorcontrib><creatorcontrib>NIKITIN, PAVEL A</creatorcontrib><creatorcontrib>ROBINSON, MATTHEW K</creatorcontrib><creatorcontrib>LUNDGREN, KAREN</creatorcontrib><creatorcontrib>DOWLING, JOHN P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HARMAN, BEN</au><au>NIKITIN, PAVEL A</au><au>ROBINSON, MATTHEW K</au><au>LUNDGREN, KAREN</au><au>DOWLING, JOHN P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IL-38-SPECIFIC ANTIBODIES</title><date>2021-02-04</date><risdate>2021</risdate><abstract>This invention relates to antibodies specific for human interleukin-38 (IL-38), including isolated antibodies, or antigen-binding fragments thereof. The antibodies, or antigen-binding fragments thereof, described here partially or fully block, inhibit, or neutralize a biological activity of IL 38. Methods described here relate to inhibiting tumor growth or metastasis in an individual afflicted by tumor growth and/or metastasis. La présente invention concerne des anticorps spécifiques de l'interleukine 38 humaine (IL-38) comprenant des anticorps isolés ou leurs fragments de liaison à l'antigène. Les anticorps ou leurs fragments de liaison à l'antigène susmentionnés bloquent, inhibent ou neutralisent, partiellement ou totalement, une activité biologique de l'IL-38. Les procédés susmentionnés concernent l'inhibition de la croissance tumorale ou de la métastase chez un individu présentant une croissance tumorale et/ou une métastase.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA3149198A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title IL-38-SPECIFIC ANTIBODIES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A03%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HARMAN,%20BEN&rft.date=2021-02-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3149198A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true